-
Founded in:
1994-12-28 -
Country:
China -
Address:
No. 1166, Zhengyang Street, Zhaodong City, Suihua City, Heilongjiang Province -
Tax NO.:
912312001313217015 -
Registered Funds:
78.54 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Acetylsalicylic acid |
It can inhibit the synthesis of prostaglandins and has antipyretic and analgesic effects
More
It can inhibit the synthesis of prostaglandins and has antipyretic and analgesic effects |
250mg | 50-78-2 | 35 |
| Ascorbic Acid |
Can enhance the body's resistance
More
Can enhance the body's resistance |
25mg | 50-81-7 | 28 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ranitidine Hydrochloride |
H2 receptor antagonist, can significantly inhibit the basal and nocturnal gastric acid secretion of normal people and ulcer patients, as well as the gastric acid secretion caused by pentagastrin, histamine and meals. It has higher selectivity for H2 receptors and its gastric acid inhibition effect is 5 to 12 times stronger than that of cimetidine. Intravenous injection of this product can reduce gastric acid secretion by 90%; it has a certain inhibitory effect on the secretion of pepsinogen. It has a protective effect on experimental gastric mucosal damage and acute ulcers. It has no effect on the secretion of gastrin and sex hormones.
More
H2 receptor antagonist, can significantly inhibit the basal and nocturnal gastric acid secretion of normal people and ulcer patients, as well as the gastric acid secretion caused by pentagastrin, histamine and meals. It has higher selectivity for H2 receptors and its gastric acid inhibition effect is 5 to 12 times stronger than that of cimetidine. Intravenous injection of this product can reduce gastric acid secretion by 90%; it has a certain inhibitory effect on the secretion of pepsinogen. It has a protective effect on experimental gastric mucosal damage and acute ulcers. It has no effect on the secretion of gastrin and sex hormones. |
66357-59-3 | 49 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Doxofylline |
By inhibiting the effects of phosphodiesterase in smooth muscle cells, it relaxes smooth muscles and thus achieves the effect of suppressing asthma.
More
By inhibiting the effects of phosphodiesterase in smooth muscle cells, it relaxes smooth muscles and thus achieves the effect of suppressing asthma. |
69975-86-6 | 28 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Doxofylline |
Doxofylline is a derivative of methylxanthine. It is a bronchodilator that can directly act on the bronchi and relax bronchial smooth muscles. It relaxes smooth muscles by inhibiting phosphodiesterase in smooth muscle cells, thereby suppressing asthma.
More
Doxofylline is a derivative of methylxanthine. It is a bronchodilator that can directly act on the bronchi and relax bronchial smooth muscles. It relaxes smooth muscles by inhibiting phosphodiesterase in smooth muscle cells, thereby suppressing asthma. |
69975-86-6 | 28 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Doxofylline |
Doxofylline is a derivative of methylxanthine. It is a bronchodilator that can directly act on the bronchi and relax bronchial smooth muscles. It relaxes smooth muscles by inhibiting phosphodiesterase in smooth muscle cells, thereby suppressing asthma.
More
Doxofylline is a derivative of methylxanthine. It is a bronchodilator that can directly act on the bronchi and relax bronchial smooth muscles. It relaxes smooth muscles by inhibiting phosphodiesterase in smooth muscle cells, thereby suppressing asthma. |
69975-86-6 | 28 |